Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes

NCT04324229 is registered in ClinicalTrials.gov with Turku University Hospital as lead sponsor.

NCT NCT04324229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04324229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes
Lead sponsor
Turku University Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 7, 2020
Completion date
December 31, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gestational diabetes